When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABBV - Idera teams up with AbbVie in cancer combo therapies
AbbVie Inc.
Idera Pharmaceuticals (NASDAQ:IDRA) will collaborate with AbbVie (NYSE:ABBV) on a three-arm Phase 1b open-label clinical trial evaluating combinations of an OX40 agonist (ABBV-368), a TLR-9 agonist (tilsotolimod), chemotherapy (nab-paclitaxel) and/or an anti-programmed cell death 1 (PD-1) antagonist (ABBV-181) stimulate the immune system resulting in anti-tumor responses.
More news on: Idera Pharmaceuticals, Inc., AbbVie Inc., Healthcare stocks news, Stocks on the move,